孤雌内酯
化学
肝细胞癌
药理学
细胞培养
细胞凋亡
IC50型
药品
癌症研究
体外
生物化学
生物
遗传学
作者
Yahui Ding,Shengzu Li,Weizhi Ge,Zhong-Quan Liu,Xuhai Zhang,Mengmeng Wang,Tianyang Chen,Yue Chen,Quan Zhang
标识
DOI:10.1016/j.ejmech.2019.111706
摘要
A series of twenty-three parthenolide-5-fluorouracil (5-FU) conjugates ware synthesized and evaluated for their anti-cancer activities against human hepatocellular carcinoma cell line Bel-7402 and 5-fluorouracil resistant human hepatocellular carcinoma cell line Bel-7402/5-FU. The preliminary structure-activity relationships were discussed. The most active compound 15d showed high activity against Bel-7402/5-FU cell line with IC50 value of 2.25 μM, which demonstrated 5.8-fold improvement compared to that of the parent compound parthenolide (IC50 = 12.98 μM). The investigation of preliminary molecular mechanism of 15d revealed that 15d could reverse drug resistance by inhibiting MDR1, ABCC1 and ABCG2 to increase the intracellular drug accumulation and induce apoptosis of Bel-7402/5-FU cells through mitochondria mediated pathway. On the base of these results, compound 15d is deserved to be further investigated as a potential anti-HCC lead compound for ultimate discovery of pathenolide-based anti-cancer drug.
科研通智能强力驱动
Strongly Powered by AbleSci AI